StockData
Astrana Health, Inc. logo

Astrana Health, Inc. (ASTH) stock

ASTHNasdaqServices-Management Consulting ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 8/3024% above fair value
$32.87+1.07 (+3.36%)

Close on Nov 16, 2026Market cap $1.83BP/E 40.1Yield –

Astrana Health price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Astrana Health's price to sales ratio was 0.4× on Nov 11, 2026, against 0.4× a year earlier. Over the last 5 years it ranged from 0.3× to 4.3×, with a median of 1.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.4×+0.0
2025Dec 31, 20250.4×−0.5
2024Dec 31, 20240.9×−0.5
2023Dec 29, 20231.3×+0.1
2022Dec 30, 20221.3×−3.0
2021Dec 31, 20214.3×+3.3
2020Dec 31, 20201.0×−0.3
2019Dec 31, 20191.3×−13.6
2018Dec 31, 201814.9×+11.7
2017Dec 29, 20173.2×+2.2
2016Dec 30, 20161.0×−1.2
2015Dec 31, 20152.2×+0.2
2014Dec 31, 20142.0×−1.2
2013Dec 31, 20133.2×+0.6
2012Dec 31, 20122.6×+1.6
2011Dec 30, 20111.0×–

More Astrana Health figures

See a number that looks wrong?